| A survey of deep-learning applications in ultrasound: Artificial intelligence–powered ultrasound for improving clinical workflow Z Akkus, J Cai, A Boonrod, A Zeinoddini, AD Weston, KA Philbrick, ... Journal of the American College of Radiology 16 (9), 1318-1328, 2019 | 239 | 2019 |
| Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double‐blind, placebo‐controlled trial A Zeinoddini, M Sorayani, E Hassanzadeh, M Arbabi, M Farokhnia, ... Depression and anxiety 32 (3), 167-173, 2015 | 121 | 2015 |
| RIL-Contour: a Medical Imaging Dataset Annotation Tool for and with Deep Learning KA Philbrick, AD Weston, Z Akkus, TL Kline, P Korfiatis, T Sakinis, ... Journal of digital imaging 32, 571-581, 2019 | 119 | 2019 |
| Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ... Bipolar disorders 17 (6), 606-614, 2015 | 98 | 2015 |
| Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial H Emadi-Kouchak, P Mohammadinejad, A Asadollahi-Amin, ... International clinical psychopharmacology 31 (1), 20-26, 2016 | 79 | 2016 |
| Partial lateral internal sphincterotomy versus combined botulinum toxin A injection and topical diltiazem in the treatment of chronic anal fissure: a randomized clinical trial H Gandomkar, A Zeinoddini, R Heidari, HA Amoli Diseases of the Colon & Rectum 58 (2), 228-234, 2015 | 78 | 2015 |
| Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial M Shalbafan, P Mohammadinejad, SV Shariat, K Alavi, A Zeinoddini, ... Pharmacopsychiatry 48 (04/05), 136-140, 2015 | 70 | 2015 |
| Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial SH Abbasi, P Mohammadinejad, N Shahmansouri, A Salehiomran, ... Journal of Affective Disorders 183, 149-155, 2015 | 69 | 2015 |
| Minocycline combination therapy with fluvoxamine in moderate‐to‐severe obsessive–compulsive disorder: A placebo‐controlled, double‐blind, randomized trial S Esalatmanesh, Z Abrishami, A Zeinoddini, F Rahiminejad, M Sadeghi, ... Psychiatry and clinical neurosciences 70 (11), 517-526, 2016 | 60 | 2016 |
| Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: R andomized, double‐blind, placebo‐controlled study S Emamzadehfard, A Kamaloo, K Paydary, A Ahmadipour, A Zeinoddini, ... Psychiatry and Clinical Neurosciences 70 (8), 332-341, 2016 | 60 | 2016 |
| Laparoscopic gastric plication versus mini-gastric bypass surgery in the treatment of morbid obesity: a randomized clinical trial S Darabi, M Talebpour, A Zeinoddini, R Heidari Surgery for Obesity and Related Diseases 9 (6), 914-919, 2013 | 55 | 2013 |
| Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial E Salardini, A Zeinoddini, P Mohammadinejad, MR Khodaie-Ardakani, ... Journal of psychiatric research 75, 24-30, 2016 | 54 | 2016 |
| Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial A Ghaleiha, R Alikhani, MR Kazemi, MR Mohammadi, ... Journal of child and adolescent psychopharmacology 26 (9), 784-791, 2016 | 49 | 2016 |
| Celecoxib versus diclofenac in mild to moderate depression management among breast cancer patients: A double-blind, placebo-controlled, randomized trial P Mohammadinejad, P Arya, M Esfandbod, A Kaviani, M Najafi, L Kashani, ... Annals of Pharmacotherapy 49 (9), 953-961, 2015 | 49 | 2015 |
| The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ... Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016 | 46 | 2016 |
| Effect of memantine combination therapy on symptoms in patients with moderate‐to‐severe depressive disorder: randomized, double‐blind, placebo‐controlled study M Amidfar, M Khiabany, A Kohi, E Salardini, M Arbabi, M Roohi Azizi, ... Journal of clinical pharmacy and therapeutics 42 (1), 44-50, 2017 | 41 | 2017 |
| A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania SY Mousavi, R Khezri, MA Karkhaneh-Yousefi, P Mohammadinejad, ... Journal of Child and Adolescent Psychopharmacology 27 (6), 494-500, 2017 | 40 | 2017 |
| Agomelatine as a treatment for attention-deficit/hyperactivity disorder in children and adolescents: a double-blind, randomized clinical trial E Salardini, A Zeinoddini, A Kohi, MR Mohammadi, P Mohammadinejad, ... Journal of child and adolescent psychopharmacology 26 (6), 513-519, 2016 | 35 | 2016 |
| Celecoxib for the treatment of mild‐to‐moderate depression due to acute brucellosis: a double‐blind, placebo‐controlled, randomized trial S Jafari, SG Ashrafizadeh, A Zeinoddini, M Rasoulinejad, P Entezari, ... Journal of clinical pharmacy and therapeutics 40 (4), 441-446, 2015 | 34 | 2015 |
| L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial A Zeinoddini, M Ahadi, M Farokhnia, F Rezaei, M Tabrizi, S Akhondzadeh Journal of psychiatric research 59, 125-131, 2014 | 32 | 2014 |
